These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

291 related items for PubMed ID: 3114409

  • 1. In vivo treatment of (NZB X NZW)F1 lupus-like nephritis with monoclonal antibody to gamma interferon.
    Jacob CO, van der Meide PH, McDevitt HO.
    J Exp Med; 1987 Sep 01; 166(3):798-803. PubMed ID: 3114409
    [Abstract] [Full Text] [Related]

  • 2. Animal models utilized in the research of autoimmune disease control: experimental therapy of glomerulonephritis in NZB/W F1 mice.
    Okudaira H, Terada E, Okudaira K.
    Prog Clin Biol Res; 1987 Sep 01; 229():157-74. PubMed ID: 3601985
    [Abstract] [Full Text] [Related]

  • 3. CXCR3 promotes the production of IgG1 autoantibodies but is not essential for the development of lupus nephritis in NZB/NZW mice.
    Moser K, Kalies K, Szyska M, Humrich JY, Amann K, Manz RA.
    Arthritis Rheum; 2012 Apr 01; 64(4):1237-46. PubMed ID: 22006377
    [Abstract] [Full Text] [Related]

  • 4. Treatment of lupus-prone NZB/NZW F1 mice with recombinant soluble Fc gamma receptor II (CD32).
    Werwitzke S, Trick D, Sondermann P, Kamino K, Schlegelberger B, Kniesch K, Tiede A, Jacob U, Schmidt RE, Witte T.
    Ann Rheum Dis; 2008 Feb 01; 67(2):154-61. PubMed ID: 17557887
    [Abstract] [Full Text] [Related]

  • 5. Experimental therapy of systemic lupus erythematosus: the treatment of NZB/W mice with mouse soluble interferon-gamma receptor inhibits the onset of glomerulonephritis.
    Ozmen L, Roman D, Fountoulakis M, Schmid G, Ryffel B, Garotta G.
    Eur J Immunol; 1995 Jan 01; 25(1):6-12. PubMed ID: 7843255
    [Abstract] [Full Text] [Related]

  • 6. Immunization with pentraxin 3 (PTX3) leads to anti-PTX3 antibody production and delayed lupus-like nephritis in NZB/NZW F1 mice.
    Gatto M, Ghirardello A, Luisetto R, Bassi N, Fedrigo M, Valente M, Valentino S, Del Prete D, Punzi L, Doria A.
    J Autoimmun; 2016 Nov 01; 74():208-216. PubMed ID: 27405845
    [Abstract] [Full Text] [Related]

  • 7. Toxoplasma gondii infection inhibits the development of lupus-like syndrome in autoimmune (New Zealand Black x New Zealand White) F1 mice.
    Chen M, Aosai F, Norose K, Mun HS, Ishikura H, Hirose S, Piao LX, Fang H, Yano A.
    Int Immunol; 2004 Jul 01; 16(7):937-46. PubMed ID: 15148287
    [Abstract] [Full Text] [Related]

  • 8. The Ox40/Ox40 Ligand Pathway Promotes Pathogenic Th Cell Responses, Plasmablast Accumulation, and Lupus Nephritis in NZB/W F1 Mice.
    Sitrin J, Suto E, Wuster A, Eastham-Anderson J, Kim JM, Austin CD, Lee WP, Behrens TW.
    J Immunol; 2017 Aug 15; 199(4):1238-1249. PubMed ID: 28696253
    [Abstract] [Full Text] [Related]

  • 9. Function of the Th17/interleukin-17A immune response in murine lupus nephritis.
    Schmidt T, Paust HJ, Krebs CF, Turner JE, Kaffke A, Bennstein SB, Koyro T, Peters A, Velden J, Hünemörder S, Haag F, Steinmetz OM, Mittrücker HW, Stahl RA, Panzer U.
    Arthritis Rheumatol; 2015 Feb 15; 67(2):475-87. PubMed ID: 25385550
    [Abstract] [Full Text] [Related]

  • 10. T cell cytokine imbalance towards production of IFN-gamma and IL-10 in NZB/W F1 lupus-prone mice is associated with autoantibody levels and nephritis.
    Enghard P, Langnickel D, Riemekasten G.
    Scand J Rheumatol; 2006 Feb 15; 35(3):209-16. PubMed ID: 16766368
    [Abstract] [Full Text] [Related]

  • 11. Critical comparative analyses of anti-alpha-actinin and glomerulus-bound antibodies in human and murine lupus nephritis.
    Kalaaji M, Sturfelt G, Mjelle JE, Nossent H, Rekvig OP.
    Arthritis Rheum; 2006 Mar 15; 54(3):914-26. PubMed ID: 16508974
    [Abstract] [Full Text] [Related]

  • 12. Inhibition of lupus disease by anti-double-stranded DNA antibodies of the IgM isotype in the (NZB x NZW)F1 mouse.
    Werwitzke S, Trick D, Kamino K, Matthias T, Kniesch K, Schlegelberger B, Schmidt RE, Witte T.
    Arthritis Rheum; 2005 Nov 15; 52(11):3629-38. PubMed ID: 16255055
    [Abstract] [Full Text] [Related]

  • 13. IFN-gamma receptor deletion prevents autoantibody production and glomerulonephritis in lupus-prone (NZB x NZW)F1 mice.
    Haas C, Ryffel B, Le Hir M.
    J Immunol; 1998 Apr 15; 160(8):3713-8. PubMed ID: 9558072
    [Abstract] [Full Text] [Related]

  • 14. Prevention of lupus nephritis development in NZB/NZW mice by selective blockade of CD28.
    Laurent L, Le Fur A, Bloas RL, Néel M, Mary C, Moreau A, Poirier N, Vanhove B, Fakhouri F.
    Eur J Immunol; 2017 Aug 15; 47(8):1368-1376. PubMed ID: 28631301
    [Abstract] [Full Text] [Related]

  • 15. Reversal of advanced murine lupus in NZB/NZW F1 mice by treatment with monoclonal antibody to L3T4.
    Wofsy D, Seaman WE.
    J Immunol; 1987 May 15; 138(10):3247-53. PubMed ID: 3106478
    [Abstract] [Full Text] [Related]

  • 16. EZH2 Inhibition Interferes With the Activation of Type I Interferon Signaling Pathway and Ameliorates Lupus Nephritis in NZB/NZW F1 Mice.
    Wu L, Jiang X, Qi C, Zhang C, Qu B, Shen N.
    Front Immunol; 2021 May 15; 12():653989. PubMed ID: 33868295
    [Abstract] [Full Text] [Related]

  • 17. Thymic microenvironment and NZB mice: the abnormal thymic microenvironment of New Zealand mice correlates with immunopathology.
    Takeoka Y, Taguchi N, Kotzin BL, Bennett S, Vyse TJ, Boyd RL, Naiki M, Konishi J, Ansari AA, Shultz LD, Gershwin ME.
    Clin Immunol; 1999 Mar 15; 90(3):388-98. PubMed ID: 10075868
    [Abstract] [Full Text] [Related]

  • 18. Suppression of renal disease and mortality in the female NZB x NZW F1 mouse model of systemic lupus erythematosus (SLE) by chenodeoxycholic acid.
    Suwannaroj S, Lagoo A, McMurray RW.
    Lupus; 2001 Mar 15; 10(8):562-7. PubMed ID: 11530998
    [Abstract] [Full Text] [Related]

  • 19. Treatment of (NZB x NZW)F1 disease with anti-I-A monoclonal antibodies.
    Adelman NE, Watling DL, McDevitt HO.
    J Exp Med; 1983 Oct 01; 158(4):1350-5. PubMed ID: 6578293
    [Abstract] [Full Text] [Related]

  • 20. Spontaneous autoimmune disease in (NZB x NZW)F1 mice is ameliorated by treatment with methimazole.
    Mozes E, Zinger H, Kohn LD, Singer DS.
    J Clin Immunol; 1998 Mar 01; 18(2):106-13. PubMed ID: 9533654
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.